"Dr Itescu added: “I am very confident that the cost reduction strategies we have implemented, together with operational streamlining and access to additional sources of capital, will facilitate the balance sheet strength needed to complete our Phase 3 programs for adults with SR-aGVHD and for chronic inflammatory low back pain through to product approvals and commercialization.”
let's hope his "very confident" is warranted!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.025(2.38%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.06 | $1.06 | $1.02 | $5.734M | 5.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 203347 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 125348 | 6 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.03 |
Change
-0.025 ( 2.94 %) |
||||
| Open | High | Low | Volume | ||
| $1.06 | $1.06 | $1.02 | 953870 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| MSB (ASX) Chart |